[Pathogenesis of hemorrhagic syndrome of the newborn infant].
D001778:Blood Coagulation Disorders / Q000453:epidemiology; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D001791:Blood Platelet Disorders / Q000453:epidemiology; D001925:Brain Damage, Chronic / Q000150:complications; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D005860:Germany, West; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time; D012189:Retrospective Studies; D014812:Vitamin K / Q000627:therapeutic use; D006475:Vitamin K Deficiency Bleeding / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control
D001779:Blood Coagulation Factors; D014812:Vitamin K; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005340:Fibrinogen
Pathogenese des hämorrhagischen Syndroms Neugeborener.